FoRx Therapeutics
Basel, CH · 3 known investors
FoRx Therapeutics is a clinical-stage biotechnology company developing small-molecule drugs that target DNA replication stress in treatment-resistant cancers. Its focus is on targeted anticancer therapies within oncology and the DNA Damage Response field.
BiotechDeep TechHealthtech
Investors · 3
Funding
SEC filings, press & company announcements$50M disclosed across 1 round · 2025
- $50MSeries ADec 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does FoRx Therapeutics do?
- FoRx Therapeutics is a clinical-stage biotechnology company developing small-molecule drugs that target DNA replication stress in treatment-resistant cancers. Its focus is on targeted anticancer therapies within oncology and the DNA Damage Response field.
- Who are FoRx Therapeutics's investors?
- FoRx Therapeutics's investors include Novartis Venture Fund, Pfizer Venture Investments, M Ventures.
- How much funding has FoRx Therapeutics raised?
- FoRx Therapeutics has disclosed $50M raised across 1 round.
- Where is FoRx Therapeutics headquartered?
- FoRx Therapeutics is headquartered in Basel, CH.